How to Check Digoxin Level
Draw a serum digoxin level at least 6-8 hours after the last dose (ideally just before the next scheduled dose) to allow adequate time for tissue equilibration, and target a therapeutic range of 0.5-0.9 ng/mL to minimize mortality risk while maintaining efficacy. 1
When to Obtain Digoxin Levels
Routine Monitoring Indications
- Suspected digoxin toxicity (cardiac arrhythmias, GI symptoms, neurological complaints)
- Assessment of therapeutic adequacy in patients on chronic therapy
- After initiating drugs that increase digoxin levels (amiodarone, dronedarone, clarithromycin, erythromycin, itraconazole, cyclosporine, propafenone, verapamil, quinidine) 1
- In high-risk populations: elderly (>70 years), impaired renal function, low lean body mass 1
Critical Timing for Sample Collection
The timing of blood draw is absolutely critical - failure to wait for tissue equilibration is a common pitfall that leads to falsely elevated levels 2:
- Optimal timing: Just before the next scheduled dose (trough level)
- Minimum wait time: At least 6-8 hours after the last dose, regardless of route of administration
- Once-daily dosing: Levels will be 10-25% lower at 24 hours versus 8 hours post-dose (depending on renal function)
- Twice-daily dosing: Minor differences between 8 and 12 hours post-dose 2
Interpreting Digoxin Levels
Target Therapeutic Range
The evidence strongly supports a lower therapeutic target than historically used 1:
- Recommended range: 0.5-0.9 ng/mL (2013 ACC/AHA Guidelines)
- Older range of 0.5-1.0 ng/mL may still be referenced (2009 guidelines) 3
- Historical range of 0.8-2.0 ng/mL is outdated and associated with increased mortality 2
The 2013 ACC/AHA guidelines narrowed the upper limit to 0.9 ng/mL based on retrospective analyses showing that levels >1.0 ng/mL were associated with increased risk-adjusted mortality without superior outcomes 1. Efficacy at lower concentrations (0.5-0.9 ng/mL) was equivalent to higher concentrations 1.
Toxicity Thresholds
- Overt toxicity: Commonly associated with levels >2.0 ng/mL 1
- Important caveat: One-third of patients with clinical toxicity have levels <2.0 ng/mL 2
- Increased sensitivity: Toxicity can occur at lower levels with hypokalemia, hypomagnesemia, or hypothyroidism 1
Clinical Context is Paramount
Never use an isolated digoxin level alone to guide therapy 2:
- About two-thirds of adequately digitalized patients (without toxicity) have levels of 0.8-2.0 ng/mL
- Digoxin may produce clinical benefits even below the therapeutic range
- Rarely, patients cannot tolerate digoxin at levels <0.8 ng/mL
- Always interpret the level in the overall clinical context 2
Common Pitfalls in Interpretation
Factors That Confound Results
- Inappropriate sampling time - most common error
- Drug interactions elevating levels (see above)
- Renal dysfunction - elevates levels and prolongs half-life
- Low lean body mass - particularly in elderly patients 1
- Exercise - may acutely decrease serum levels due to increased skeletal muscle binding (without affecting efficacy) 2
- Laboratory issues:
- Cross-reactivity with digoxin metabolites
- Spironolactone can cause false elevations with some assays (though spironolactone doesn't actually affect digoxin disposition) 3
- Technical/analytical errors
When Discrepancies Exist
If the reported level doesn't match clinical response, consider 2:
- Analytical problems in the assay
- Inappropriate sampling time
- Administration of a different digitalis glycoside
- Conditions altering patient sensitivity to digoxin (electrolyte abnormalities, thyroid dysfunction)
Practical Dosing Considerations
Standard maintenance dosing: 0.125-0.25 mg daily 1
Reduce to 0.125 mg daily or every other day if 1:
- Age >70 years
- Impaired renal function
- Low lean body mass
Higher doses (0.375-0.50 mg daily) are rarely needed and increase toxicity risk without additional benefit 1.